Keeping Current CME podcast

Current and Future Oral SERD Strategies in the Management of ER-Positive/HER2-Negative MBC: Analyzing the Clinical Data

0:00
29:08
Rewind 15 seconds
Fast Forward 15 seconds

Did you know that as MBC patients get treated with multiple lines of ET, the percentage of patients who develop an ESR1 mutation increases?

Credit available for this activity expires: 1/26/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/current-and-future-oral-serd-strategies-management-er-2026a100022b?ecd=bdc_podcast_libsyn_mscpedu

More episodes from "Keeping Current CME"